New Square Capital LLC Vertex Pharmaceuticals Inc Transaction History

New Square Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$338.18 - $362.46 $16,570 - $17,760	49 Added 490.0%	59 $20,000
Q4 2022 Feb 06, 2023	BUY	$285.76 - $321.48 $2,857 - $3,214	10 New	10 $2,000
Q3 2020 Nov 04, 2020	SELL	$255.65 - $303.1 $1.42 Million - $1.68 Million	-5,535 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$225.48 - $295.8 $220,970 - $289,884	980 Added 21.51%	5,535 $1.61 Million
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $909,952 - $1.13 Million	4,555 New	4,555 $1.08 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

Stay updated on New Square Capital LLC with notifications on news.